FDA Approves Genio® 2.1 For Use in DREAM U.S. IDE Pivotal Study
FDA Approves Genio® 2.1 For Use in DREAM U.S. IDE Pivotal Study New smartphone application, upgraded activation chip, improved user interface, and stimulation amplitude trimming enhance patient experience and comfort…